Order byBest matchMost fresh

Peter Marks, FDA and Biotech

Digest more
Top News
Event details
Impacts
Markets Insider |
RBC Capital analyst Brian Abrahams warned that Marks’ exit could lead to disruptions at the FDA, affecting drug approvals and regulatory flexibility.
Reuters |
Peter Marks, who played a key role in President Donald Trump's first term in developing COVID-19 vaccines, will leave effective April 5, the Wall Street Journal and other media outlets reported on Fr...
U.S. News & World Report |
Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine official at the U.S. Food and Drug Administration had resigned, fanning worries over slowe...

Read more on News Digest

Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research
Biotech Stocks Fall As FDA's Peter Marks Resigns
Vaccine and biotech stocks plummeted after Peter Marks, a top regulator at the US Food and Drug Administration, resigned due to friction with Health and Human Services Secretary Robert F. Kennedy Jr.
Follow the Science: Why Peter Marks Was Asked to Leave the FDA
Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for Biologics Evaluation and Research) citing differences with Health and Human Services (HHS) Secretary Kennedy regarding vaccines.
Drugmakers sink after key FDA official ousted as Trump plans health overhaul
Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official, Peter Marks, had been forced to resign, the most high-profile exit at the regulator as the Trump administration undertakes an overhaul of federal health agencies.
Moderna (NASDAQ:MRNA) Leads U.S. Biotechs’ Plunge after FDA’s Top Vaccine Regulator Resigns
Shares of some U.S. biotechnology companies including Moderna (MRNA) plunged on Monday after reports that the top vaccine official at the U.S.
Biotech Investors Rush for the Exits After FDA Official Resigns
Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and champio
Biotech Stocks Tumble on Reports FDA's Top Vaccine Regulator to Leave
Greg Nash/Pool via REUTERS (Reuters) -Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine official at the U.S. Food and Drug Administration had resigned,
Pharmaceutical Stocks Dive as Top FDA Vaccine Regulator Departs
Director of the Center for Biologics Evaluation and Research, is leaving the regulator as the new Health and Human Services Secretary, Robert F. Kennedy Jr., cleans house. The latest reports indicate that Marks was forced to resign as RFK makes major changes to how the regulator operates.
FDA's top tobacco official is removed from post in latest blow to health agency's leadership
The Food and Drug Administration’s chief tobacco regulator has been removed from his post amid sweeping cuts at the agency and across the federal health workforce handed down Tuesday, according to people familiar with the matter.
STAT9h
Marks’ exit is not exactly helping industry sentiment
Vaccine makers were hit particularly hard yesterday, as Marks’ resignation letter alluded to disagreements with HHS Secretary Robert F. Kennedy Jr. on vaccines. Moderna’s stock dropped 9%, while Vaxcyte’s plummeted 46% (though shares of Vaxcyte were also affected by disappointing results of a vaccine candidate.)
Dr. Peter Marks, top vaccine official at FDA, resigns and criticizes RFK Jr.
Dr. Peter Marks, the top vaccine official at the Food and Drug Administration, wrote in a letter that he was resigning from his position.
Who Is Dr. Peter Marks? FDA’s Top Vaccine Official Quits, Citing RFK Jr.’s ‘Misinformation And Lies.’
Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented assault on scientific truth” impacting public health.
Fierce Pharma9h
FDA's new commissioner Marty Makary signed off on Peter Marks ouster: Politico
It's not yet been a week since Marty Makary, M.D., was confirmed to lead the FDA as its commissioner. | Peter Marks, M.D., Ph.D., a target for RFK Jr. and allies, last week turned in his resignation as director of the FDA's Center for Biologics Evaluation and Research.
Billie Lourd Marks Late Grandmother Debbie Reynolds' 93rd Birthday with Touching Throwback Photo
Billie Lourd celebrated her late grandmother Debbie Reynolds' 93rd birthday with a throwback photo on social media.
Explore more
S&P 500 marks its worst quarter since 2022 amid tariff and inflation fears
During the first three months of 2025, the S&P 500 lost 4.6%, marking the worst quarter in two-and-a-half years. The tech-heavy Nasdaq composite ended the first three months of the year with a 10.4% decline, while the Dow Jones Industrial Average shed 2.2% over the same period.
Wrinkles begone: Dermatologists reveal the best lasers for lines, sagging, stretch marks and spots
Discover the best laser treatments for scars, stretch marks, sagging, fine lines and wrinkles. The Post consulted two experts to help you choose the right option for your skin.
Moncton Wildcats' Gardiner MacDougall: Aiming for Championship Glory in QMJHL
Gardiner MacDougall's transition from the University of New Brunswick (UNB) to the Moncton Wildcats marks an exciting new chapter in his illustrious coaching career. Retiring from UNB after securing his ninth U Sports title last season,
Feedback